JPH0260306B2 - - Google Patents
Info
- Publication number
- JPH0260306B2 JPH0260306B2 JP58151351A JP15135183A JPH0260306B2 JP H0260306 B2 JPH0260306 B2 JP H0260306B2 JP 58151351 A JP58151351 A JP 58151351A JP 15135183 A JP15135183 A JP 15135183A JP H0260306 B2 JPH0260306 B2 JP H0260306B2
- Authority
- JP
- Japan
- Prior art keywords
- monolinolein
- blood cholesterol
- effect
- suppressing
- lowering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- WECGLUPZRHILCT-GSNKCQISSA-N 1-linoleoyl-sn-glycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@@H](O)CO WECGLUPZRHILCT-GSNKCQISSA-N 0.000 claims description 22
- USPSDZQQNLMVMK-UHFFFAOYSA-N 1-Monolinolein Natural products CCCCCC=CC=CCCCCCCCC(=O)OCC(O)CO USPSDZQQNLMVMK-UHFFFAOYSA-N 0.000 claims description 21
- 235000013361 beverage Nutrition 0.000 claims description 7
- IEPGNWMPIFDNSD-HZJYTTRNSA-N 2-linoleoylglycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(CO)CO IEPGNWMPIFDNSD-HZJYTTRNSA-N 0.000 claims description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 38
- 210000004369 blood Anatomy 0.000 description 16
- 239000008280 blood Substances 0.000 description 16
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 235000013322 soy milk Nutrition 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- -1 glycerin fatty acid esters Chemical class 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000002378 plant sterols Nutrition 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 235000015197 apple juice Nutrition 0.000 description 2
- 235000014171 carbonated beverage Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 239000002285 corn oil Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 235000021053 average weight gain Nutrition 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Landscapes
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Description
本発明は血中コレステロールの低下または上昇
抑制作用を有した飲料に関するものである。本発
明でいう飲料は、豆乳、牛乳、果汁、清涼飲料、
栄養飲料、炭酸飲料などをいう。ここでいう血中
コレステロールを低下させる作用とは血中コレス
テロール濃度が通常より高いものに対し、これを
低下させる作用をいいまた血中コレステロールの
上昇を抑制する作用とはコレステロールを多量に
含む食品を摂取しても、恒常的に血中コレステロ
ールが上昇することを抑える作用をいう。
従来の数多くの知見を基にすると、植物油中の
多価不飽和脂肪酸(リノール酸など)や植物ステ
ロールなどはヒトや他の動物の血中コレステロー
ルを低下または上昇抑制作用を有することは良く
知られている。近年、この種の物質が食品または
飲料に栄養改善を目的に補足強化された健康食品
として実用化されてきた。
本発明者らは、従来より明らかにされた上記物
質以外の油脂成分の生理効果の有無に注目し、
種々検討した結果、モノグリセリドの一種のモノ
リノレインには従来の物質に比し100分の1の量
で血中コレステロールの低下作用および上昇抑制
作用が同等の効果を示すことを見出し、本発明を
完成した。すなわち、本発明は飲料中にモノリノ
レインを0.1重量%ないし30重量%含有せしめた
飲料である。
ここでいうモノリノレインはα−モノリノレイ
ンおよび/またはβ−モノリノレインをいう。特
にβ−モノリノレインに優れた効果がある。
本発明に用いるモノリノレインの調製法には特
に制限はなく、天然モノグリセリドの濃縮または
分取のほか、アルカリ類やP−トルエンスルホン
酸等の触媒または酵素を用いたグリセリンの直接
エステル化、エステル交換およびトリグリセイ
ド、ジグリセイドの部分加水分解をはじめ公知の
合成法が利用でき、さらにこれらを組み合わせて
用いてもよい。
このようにして得られたモノリノレインは、そ
のままでもまた水や油脂類に溶解あるいは分散さ
せて用いることもでき、広範囲の飲料に添加が可
能であり、しかも少量の添加で血中コレステロー
ルを低下させるまたは上昇を抑制するから食生活
を改善に寄与するところ大である。
本発明によれば水を主成分とした溶得にモノリ
ノレインを0.1%〜30%、好ましくは1%〜5%
溶解あるいは分散させることにより、血中コレス
テロールを低下または上昇を抑制する作用を有す
る健康食料を製造することができる。この際、モ
ノリノレイン以外のグリセリン脂肪酸エステル、
シヨ糖脂肪酸エステル、ソルビタン脂肪酸エステ
ル、レシチンなどの乳化剤を用いることも可能で
ある。
本発明者らの以前の出願(特開昭57−35517号、
特開昭57−36935号、特開昭57−36936号、特開昭
57−39736号および特開昭57−42631号)に記載さ
れた発明の組成物および食用油脂に含まれる有効
生物中にはモノリノレインの他に、植物ステロー
ル及びジグリセライドを多量に含み半固型状であ
るので、これを油脂に含有させても味風味の好ま
しい飲料が得られない。ジグリセライドまたは植
物ステロールの含量はモノリノレインに対して重
量比で好ましくは5倍以下にするのがよい。
以下実施例により本発明を具体的に説明する。
実施例 1
(1) モノリノレインの調製法
−コーン油からの調製−
精製コーン油1Kgに10Kgのメチルエチルケト
ンを加えて撹拌した後、ドライアイス・メタノ
ール冷媒にて−70℃で3時間冷却した。その
後、固結物を吸引濾過により除去したメチルエ
チルケトン溶液からメチルエチルケトンをエバ
ポレータに留去し、赤かつ色の液体を得た。こ
れに10倍重量のメチルエチルケトンを加え、再
度同じ方法にて低温固結性物質を除き、メチル
エチルケトンを留去して赤かつ色の高粘度液体
25gを得た。
さらにこの物質22gを、活性化した「ワコー
ゲルC−200」1500gを充填した内径70mmのガ
ラスカラムにより第1表の溶剤にて順次展開
し、それぞれの区分を回収後、溶剤を留去し、
第2表に示すような4つのカラムの分画物質を
得た。
TECHNICAL FIELD The present invention relates to a beverage that has the effect of lowering or suppressing the increase in blood cholesterol. Beverages referred to in the present invention include soy milk, milk, fruit juice, soft drinks,
Refers to nutritional drinks, carbonated drinks, etc. The effect of lowering blood cholesterol here refers to the effect of lowering blood cholesterol concentration in those whose blood cholesterol concentration is higher than normal, and the effect of suppressing the increase in blood cholesterol refers to the effect of reducing blood cholesterol concentration in those who have higher than normal blood cholesterol concentration. It has the effect of suppressing the constant rise in blood cholesterol even when ingested. Based on a large amount of conventional knowledge, it is well known that polyunsaturated fatty acids (such as linoleic acid) and plant sterols in vegetable oils have the effect of lowering or suppressing the increase in blood cholesterol in humans and other animals. ing. In recent years, this type of substance has been put into practical use as a supplemented and fortified health food in foods or drinks for the purpose of improving nutrition. The present inventors focused on the presence or absence of physiological effects of oil and fat components other than the above-mentioned substances that have been clarified in the past,
As a result of various studies, we discovered that monolinolein, a type of monoglyceride, has the same effect on lowering and suppressing blood cholesterol levels as conventional substances at 1/100th the amount, and completed the present invention. did. That is, the present invention is a beverage containing 0.1% to 30% by weight of monolinolein. Monolinolein as used herein refers to α-monolinolein and/or β-monolinolein. In particular, β-monolinolein has excellent effects. There are no particular restrictions on the method for preparing monolinolein used in the present invention, and in addition to concentration or fractionation of natural monoglycerides, direct esterification and transesterification of glycerin using an alkali or a catalyst such as P-toluenesulfonic acid or an enzyme. Known synthetic methods including partial hydrolysis of triglyceride and diglyceride can be used, and combinations of these methods may also be used. The monolinolein obtained in this way can be used as it is or dissolved or dispersed in water or fats and oils, and can be added to a wide range of beverages, and even a small amount of it can lower blood cholesterol. It also greatly contributes to improving your eating habits because it suppresses the increase. According to the present invention, monolinolein is added in an amount of 0.1% to 30%, preferably 1% to 5%, in a water-based solution.
By dissolving or dispersing it, it is possible to produce a health food that has the effect of lowering or suppressing the increase in blood cholesterol. At this time, glycerin fatty acid esters other than monolinolein,
It is also possible to use emulsifiers such as sucrose fatty acid ester, sorbitan fatty acid ester, and lecithin. The inventors' previous application (Japanese Patent Application Laid-Open No. 57-35517,
JP-A-57-36935, JP-A-57-36936, JP-A-Sho
In addition to monolinolein, the effective organisms contained in the compositions and edible fats and oils of the invention described in Japanese Patent Application Laid-Open No. 57-39736 and JP-A No. 57-42631 contain large amounts of plant sterols and diglycerides, which are semi-solid. Therefore, even if it is included in fats and oils, a beverage with a favorable taste and flavor cannot be obtained. The content of diglyceride or plant sterol is preferably 5 times or less by weight relative to monolinolein. The present invention will be specifically explained below using Examples. Example 1 (1) Method for preparing monolinolein - Preparation from corn oil - After adding 10 kg of methyl ethyl ketone to 1 kg of refined corn oil and stirring, the mixture was cooled at -70°C for 3 hours using a dry ice/methanol refrigerant. Thereafter, methyl ethyl ketone was distilled off in an evaporator from the methyl ethyl ketone solution in which the solids were removed by suction filtration to obtain a red colored liquid. Add 10 times the weight of methyl ethyl ketone to this and use the same method again to remove the low-temperature solidifying substances.The methyl ethyl ketone is then distilled off to form a red, highly viscous liquid.
Obtained 25g. Furthermore, 22 g of this substance was sequentially developed with the solvents listed in Table 1 through a glass column with an inner diameter of 70 mm packed with 1500 g of activated "Wako Gel C-200", and after collecting each section, the solvent was distilled off.
Four columns of fractionated material were obtained as shown in Table 2.
【表】【table】
【表】
ここで得られた区分を日立ゲル3053カラム
を装着した高速液体クロマトグラフイを用い、
メタノール:イソオクタン:水=500:10:20
にて溶離させ、モノリノレイン標準品の保持時
間に相当する部分を分取した。分取されたもの
は主としてリノール酸から成るモノグリセリド
であつた。分取を繰返し、7.6gの区分より
約100mgのモノリノレイン(純度95%)を得た。
(2) 動物実験
スプラグ・ドーレ系28日令雄ラツトを2日間
市販飼料で飼育後、区分けを行い、1区10匹、
平均体重98.9±2.3gのものを用い第3表に示
した試験飼料を自由摂取させ5日間飼育した。
給餌給水は蒸溜水100gに対し第2表に示した
第4区分を0.1%、モノリノレイン0.1%または
0.3%(w/w)、乳化剤(「Tween80」)を5mg
添加しワーリングブレンダーを用い5000rpmに
て5分間処理したものを使用当日に調製し自由
摂取させた。
飼育終了後16時間絶食後エーテル麻酔下で採
血し常法により血清を採取した。血清中の総コ
レステロールは和光純薬工業(株)製キツト
「cholesterol B−Test Wako」および血清β
−リポタンパクは同じく同社のキツト「β−
Lipoprotein−Test Wako」を用いそれぞれ測
定した。飼育成績および血清総コレステロール
値と血清β−リポプロテイン値第4表に示し
た。[Table] The classification obtained here was determined using high performance liquid chromatography equipped with a Hitachi Gel 3053 column.
Methanol:isooctane:water=500:10:20
A portion corresponding to the retention time of the monolinolein standard product was collected. What was collected was monoglyceride mainly consisting of linoleic acid. The fractionation was repeated and about 100 mg of monolinolein (purity 95%) was obtained from the 7.6 g portion. (2) Animal experiment After feeding 28-day-old Sprague-Dohle male rats on commercially available feed for 2 days, they were divided into sections, with 10 rats in each section.
The mice had an average weight of 98.9±2.3 g and were raised for 5 days with free access to the test feed shown in Table 3.
For feeding water, add 0.1% of the 4th category shown in Table 2 to 100g of distilled water, 0.1% of monolinolein, or
0.3% (w/w), 5 mg emulsifier (“Tween80”)
It was prepared on the day of use and allowed to be taken ad libitum by processing it for 5 minutes at 5000 rpm using a Waring blender. After the end of rearing, blood was collected under ether anesthesia after fasting for 16 hours, and serum was collected using a conventional method. Total cholesterol in serum was measured using the kit “cholesterol B-Test Wako” manufactured by Wako Pure Chemical Industries, Ltd. and serum β.
- Lipoprotein is also produced by the company's Kittu ``β-
Each was measured using "Lipoprotein-Test Wako". The breeding results and serum total cholesterol and serum β-lipoprotein values are shown in Table 4.
【表】【table】
【表】
〓
%にする。
チヨコラD滴 0.01%〓
[Table] 〓
Make it %.
Chiyokora D drops 0.01%
【表】
以上の結果から、モノリノレインの添加による
平均増体量、平均食下量および飼料効率には全く
影響を及ぼさず、剖検所見も対照区と差異は認め
なかつた。血清総コレステロール値および血清β
−リポプロテイン値にモノリノレインの有意の効
果が認められた。
実施例 2
市販のリンゴジユース(全農(製))にモノリ
ノレインを0.2%添加して果汁を得た。
このリンゴジユースは実施例1の飲料同様の血
中コレステロールの低下または上昇抑制作用を有
していた。
実施例 3
下記配合の各原料を1000部の無菌水に溶かして
200ml容器に詰け栄養飲料とした。
糖 類 150部
混合アミノ酸 5部
エタノール 15部
モノリノレイン 3部酢酸トコフエロール 1部
この栄養飲料は実施例1の飲料同様の血中コレ
ステロールの低下または上昇抑制作用を有してい
た。
実施例 4
砂糖を溶解して糖液をつくり、これに酸味料、
香料およびその他の原料を加えて調合しシラツプ
を作り、シラツプに対し0.2%モノリノレインを
加えた。これを200mlビンに詰めた後、炭酸ガス
を圧入した水を充たして打栓し炭酸飲料とした。
実施例 5
脱皮大豆2Kgを粉砕後、10倍量の沸とう水を加
え、デイスパーズミルで分散し、さらにパイプラ
イン中で直接水蒸気と接触せしめて急激に120℃
にて30秒間加熱した。これを遠心分離してオカラ
を除去し豆乳を得た。この豆乳にモノリノレイン
0.5%を加えて分散させた。
この豆乳は実施例1の飲料同様の血中コレステ
ロールの低下または上昇抑制作用を有していた。[Table] From the above results, the addition of monolinolein had no effect on average weight gain, average food consumption, or feed efficiency, and no difference was observed in the autopsy findings from the control group. Serum total cholesterol level and serum β
-A significant effect of monolinolein on lipoprotein levels was observed. Example 2 Fruit juice was obtained by adding 0.2% monolinolein to commercially available apple juice (manufactured by Zennoh Co., Ltd.). This apple juice had the same effect of lowering or suppressing the increase in blood cholesterol as the drink of Example 1. Example 3 Dissolve each ingredient in the following formulation in 1000 parts of sterile water.
It was packed into a 200ml container and used as a nutritional drink. Sugars 150 parts Mixed amino acids 5 parts Ethanol 15 parts Monolinolein 3 parts Tocopherol acetate 1 part This nutritional drink had the same effect of lowering or suppressing the rise of blood cholesterol as the drink of Example 1. Example 4 Dissolve sugar to make a sugar solution, add acidulant,
A syrup was prepared by adding fragrance and other raw materials, and 0.2% monolinolein was added to the syrup. This was packed into 200ml bottles, filled with water injected with carbon dioxide gas, and capped to produce a carbonated drink. Example 5 After pulverizing 2 kg of dehulled soybeans, 10 times the amount of boiling water was added, dispersed in a dispersion mill, and then brought into direct contact with steam in a pipeline to be rapidly heated to 120°C.
and heated for 30 seconds. This was centrifuged to remove okara to obtain soy milk. Monolinolein in this soy milk
0.5% was added and dispersed. This soymilk had the same effect of lowering or suppressing the increase in blood cholesterol as the drink of Example 1.
Claims (1)
し30重量%含有せしめた飲料。 2 モノリノレインが、β−モノリノレインであ
る特許請求の範囲第1項記載の飲料。[Claims] 1. A beverage containing 0.1% to 30% by weight of monolinolein. 2. The beverage according to claim 1, wherein the monolinolein is β-monolinolein.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58151351A JPS6043368A (en) | 1983-08-19 | 1983-08-19 | Drink |
| EP83305367A EP0104043A3 (en) | 1982-09-20 | 1983-09-14 | Foodstuffs and pharmaceuticals |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58151351A JPS6043368A (en) | 1983-08-19 | 1983-08-19 | Drink |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6043368A JPS6043368A (en) | 1985-03-07 |
| JPH0260306B2 true JPH0260306B2 (en) | 1990-12-14 |
Family
ID=15516654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58151351A Granted JPS6043368A (en) | 1982-09-20 | 1983-08-19 | Drink |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6043368A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1303771C (en) * | 1986-02-25 | 1992-06-16 | Jerold C. Rosenfeld | Preparation of gray to blue aromatic polyesters by incorporation of cobalt into the catalyst system |
| JP2009155257A (en) * | 2007-12-26 | 2009-07-16 | Taiyo Corp | Antibacterial agent and oral composition, food and drink containing the same |
-
1983
- 1983-08-19 JP JP58151351A patent/JPS6043368A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6043368A (en) | 1985-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2067406B1 (en) | Ubiquinol-enriched fat-containing dairy products | |
| O'brien | Fats and oils: formulating and processing for applications | |
| ES2300115T5 (en) | Edible fats that contain arachidonic acid and foods that contain them | |
| US7166311B2 (en) | Process for producing fat composition containing hydrophobic components of glycyrrhiza | |
| AU2003203261B2 (en) | Ubiquinone-enriched foods | |
| WO1999048378A1 (en) | Phytosterol-containing fat composition | |
| EP2219476B1 (en) | Infant formula composition | |
| EP1483973A1 (en) | Fat or oil composition | |
| JP2000309794A (en) | Fat and oil composition | |
| Norhazlindah et al. | Techniques for extraction, characterization, and application of oil from sacha inchi (Plukenetia volubilis L.) seed: a review | |
| Battula et al. | Ghee, anhydrous milk fat and butteroil | |
| US20230404102A1 (en) | Edible microbial oil | |
| CN109924265B (en) | Oil and fat composition and oil-water composition containing same | |
| US20100316744A1 (en) | Plant sprout-based emulsions, process for preparing them and use thereof | |
| JP2020536572A (en) | Manufacturing method of monoacylglyceride oil and foods containing monoacylglyceride oil | |
| US20040166224A1 (en) | Sterol fatty acid ester composition and foods containing the same | |
| JP2001161265A (en) | Oil and fat composition | |
| US5468511A (en) | Method for removal of cholesterol and fat from liquid egg yolk with recovery of free cholesterol as a by-product | |
| JP2022151721A (en) | Sweetness promoter, fat composition for sweetness promoter, sweetness promoting method of food composition, and manufacturing method of sweetness promoter | |
| Gordon | Fats and fatty foods | |
| Henry | Processing, manufacturing, uses and labelling of fats in the food supply | |
| JPH0260306B2 (en) | ||
| JP2024122080A (en) | Fruit flavor enhancer and method for enhancing fruit flavor | |
| JP5626976B2 (en) | Acid liquid seasoning | |
| JP7406355B2 (en) | sweetness enhancer |